Overexpression of Rheb2 enhances mouse hematopoietic progenitor cell growth while impairing stem cell repopulation
Open Access
- 15 October 2009
- journal article
- Published by American Society of Hematology in Blood
- Vol. 114 (16), 3392-3401
- https://doi.org/10.1182/blood-2008-12-195214
Abstract
Molecular mechanisms preserving hematopoietic stem cell (HSC) self-renewal by maintaining a balance between proliferation, differentiation, and other processes are not fully understood. Hyperactivation of the mammalian target of rapamycin (mTOR) pathway, causing sustained proliferative signals, can lead to exhaustion of HSC repopulating ability. We examined the role of the novel ras gene Rheb2, an activator of the mTOR kinase, in colony-forming ability, survival, and repopulation of immature mouse hematopoietic cells. In a cell line model of mouse hematopoietic progenitor cells (HPCs), we found enhanced proliferation and mTOR signaling in cells overexpressing Rheb2. In addition, overexpression of Rheb2 enhanced colony-forming ability and survival of primary mouse bone marrow HPCs. Expansion of phenotypic HSCs in vitro was enhanced by Rheb2 overexpression. Consistent with these findings, Rheb2 overexpression transiently expanded phenotypically defined immature hematopoietic cells after in vivo transplantation; however, these Rheb2-transduced cells were significantly impaired in overall repopulation of primary and secondary congenic transplantation recipients. Our findings suggest that HPCs and HSCs behave differently in response to growth-promoting signals stimulated by Rheb2. These results may have value in elucidating mechanisms controlling the balance between proliferation and repopulating ability, a finding of importance in clinical uses of HPCs/HSCs.Keywords
This publication has 31 references indexed in Scilit:
- K-RasG12D expression induces hyperproliferation and aberrant signaling in primary hematopoietic stem/progenitor cellsBlood, 2006
- Mammalian Target of Rapamycin Is Required for Thrombopoietin-Induced Proliferation of Megakaryocyte ProgenitorsThe International Journal of Cell Cloning, 2006
- mTOR regulates cell survival after etoposide treatment in primary AML cellsBlood, 2005
- S6 kinase 2 potentiates interleukin-3-driven cell proliferationJournal of Leukocyte Biology, 2005
- Synergistic effect of targeting mTOR by rapamycin and depleting ATP by inhibition of glycolysis in lymphoma and leukemia cellsLeukemia, 2005
- Analysis of mTOR signaling by the small G‐proteins, Rheb and RhebL1FEBS Letters, 2005
- K-Ras is essential for normal fetal liver erythropoiesisBlood, 2005
- Inhibition of PI3K, mTOR and MEK signaling pathways promotes rapid apoptosis in B-lineage ALL in the presence of stromal cell supportLeukemia, 2004
- SDF-1α/CXCL12 enhances retroviral-mediated gene transfer into immature subsets of human and murine hematopoietic progenitor cellsGene Therapy, 2003
- A Stem Cell Molecular SignatureScience, 2002